|
|
 | | | |
- close
- close
- close
- close
Biocon (BIOCON.EQ-IN) |
QUOTE AND NEWS
The Hindu Business Line
May 23
Comment
Biocon’s Non-Executive Director and Chairman of Audit Committee, Neville Bain, died at his home in London on May 22.According to a company release, Bain joined the board of Biocon Ltd in 19...
The Hindu Business Line
May 21
Comment
Pharma MNC, biotech major had called off $350-m deal in March
The Hindu Business Line
May 17
Comment
The Koch Institute for Integrative Cancer Research, MIT, Cambridge, is looking at collaborative ties with companies such as Biocon.
Prof Tyler Jacks, Head of Koch Institute, and renowned...
The Economic Times
May 15
Comment
After the divestment of Axicorp and the snapping of its biosimilar insulin deal with Pfizer, the company was expected to post a subdued performance.
Reuters
May 3
Comment
REUTERS - Abbott Laboratories has partnered Indian biotechnology company Biocon Ltd to develop nutrition products for India, as the U.S. drugmaker steps up its push to tap a potentially big market.
PR Newswire
May 3
Comment
MUMBAI and BANGALORE, India, May 3, 2012 /PRNewswire/ -- Abbott (NYSE: ABT), one of India's largest health care companies, today announced plans to establish its first nutrition research and development center in the country in collaboration with
The Hindu Business Line
Apr 28
Comment
Biotech major Biocon plans to pursue multiple regional partner models to market insulin and insulin analogs globally.
Addressing reporters after announcing company's results, Biocon Chair...
The Economic Times
Apr 27
Comment
The stock is showing a potential but it needs to get past 244-245. If it does that, it could possibly go up to as high as about 258 to 260.
Wall Street Journal
Apr 27
Comment
Biocon, India's largest biotechnology company by revenue, beat analysts' expectations despite a 3.0% drop in fourth-quarter consolidated net profit on the back of a jump in other operating income.
The Hindu Business Line
Apr 27
Comment
Loss of licensing revenue pulled biotech major Biocon's consolidated profits down 3 per cent to Rs 97.8 crore for the fourth quarter of 2011-12.
Biopharmaceuticals income from lic...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
